Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: When PPP isn’t a welcome answer for healthcare

It is perhaps a curious line in the sand to draw, but the new hospital in Dunedin, the second-largest city in the South Island of New Zealand, is gearing up to be a significant battle in the use of private-public partnership funding in the APAC region.

At the weekend, prime minister Bill English unveiled plans for a new up to NZ$1.4 billion dollar (US$1 billion) hospital in Dunedin, in what will be the largest build of its type in the country’s history. It is also one of the most controversial. This has nothing to do with electioneering, though this charge has been made (traditionally government announcements like this are not made within three months of an election) rather it is because of the way that the hospital will be funded.

“We have been assessing the options around refurbishing the existing site and building a new hospital. The decision has been made to rebuild. This would maximise the opportunity of having a purpose-built, state-of-the-art facility, while also minimising disruption to patients and staff,” said health minister Jonathan Coleman. “The ministry of health is working to secure an appropriate site for the new hospital, with a strong preference for a central city location. Depending on the location the new hospital will be opened in seven to ten years,” he added.

But what set the cat among the pigeons was his comments on how the government planned to fund the rebuild. “Given the size of the project the government will consider all funding options including a private public partnership model,” Coleman said.

It drew an instant and angry response from Association of Salaried Medical Specialists (ASMS), the trade union that represents the professional and industrial interests of just over 4,000 senior salaried doctors and dentists, mostly employed in New Zealand District Health Boards.

“A new public hospital for Dunedin is long overdue and very welcome but it needs to be fully funded by the government instead of allowing private investors to profit at the expense of patient care,” said Ian Powell, ASMS executive director.

“If the government does go down this track in Dunedin, then it would essentially be handing over the keys for one of the country’s biggest public hospitals to private investors to maximise extracting profits for themselves. Much of these profits would come from repayments Southern DHB would be forced to pay out of its increased annual operating expenses,” he added, pointing out that PPP funding models had been tried in the UK and proved “financially disastrous”.

This is not the first time that the ASMS has lobbed against a public private model. Earlier this year it raised concerns about the funding model for a new integrated family medical centre which is planned in Westport to replace the existing Buller Hospital.

“The government is trying to force a public private partnership on the West Coast District Health Board that would take money away from patient care and hand it to third party investors,” said Powell in May. “West Coast senior doctors are distressed and angry about the financial foolishness of this shoddy deal and that money that should be spent on West Coast patients will be siphoned off to pay a third party investor.”

Westport remains controversial. On Friday more than 1,000 people demonstrated against the new medical centre and a protest march is planned for Saturday.

The new NZ$10 million centre will be completed in the first half of 2019.

But with a general election next month, healthcare is emerging as a major topic – between those who believe that healthcare is a core part of government spending, and those who believe that private sector assistance is needed. The outcome will be closely watched.

Posted on: 23/08/2017 UTC+08:00


News

Beijing-based healthcare service platform Miaoshou Doctor has completed a ¥1.5 billion (US$232 million) Series F round of financing.
Chinese digital technology company, Xisoft Technology, which focuses on hospital operation management, has raised ¥100 million ($15.65 million) in Series A+ financing.
Hearing health company Olive Union has closed a $7M Series B round led by Beyond Next Ventures, Bonds Investment Groups and Japan Policy Finance Corporation.
Long Hill Capital, a venture capital firm in China, has closed on more than $300 million for its third fund on 15 March.
Eluminex Biosciences, an ophthalmic biotechnology company has completed a $50 million Series A financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
TVM Capital Healthcare, a global private equity and growth capital firm focused on emerging markets, has announced two team additions today.
In partnership with VeChain and DNV GL, Renji Hospital, a hospital in China affiliated with the Shanghai Jiaotong University School of Medicine, has launched the world's first blockchain-enabled intelligent tumour treatment centre.
Hong Kong-based BuyHive, a new global sourcing start-up that connects buyers with trusted verified overseas suppliers, has launched a PPE programme to help US companies optimise their post-Covid supply chains.



Analysis

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


Podcasts

HealthInvestor Asia twitter feed










A Rolex Yacht-Master I Ladies Replica watch is basically a person watch that's crafted inside an identical fashion with a well-known maker¡¯s real piece. Purchasing Replica Watches seems as an excellent idea. Anyway,ON perfectcloneshop.com replica Rolex Yacht-Master Ladies watches are affordable, look almost the identical while using real ones and could easily acquired.